Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars on practical thrombosis and haemostasis issues that scientists and physicians frequently confront. These webinars will allot time for participants to ask questions and will cover the latest information on relevant topics.
Mechanisms of arterial thrombosis - Dr. Lawrence Brass will cover recent ideas about mechanisms of hemostasis and show how they provide insights into arterial thrombosis and the effects of antiplatelet agents.
Mechanisms of venous thrombosis - Dr. Steffen Massberg will address the cellular and molecular mechanisms of deep vein thrombosis. In particular, he will focus on the role of innate immune cells and he will illustrate how aberration of a physiological process entitled immunothrombosis contributes to DVT.
This meeting is supported by an unrestricted educational grant from Instrumentation Laboratory
Hematologist, cardiologist, graduate students, postdocs, clinical fellows, scientists, technologists, and medical students with an interest in the prevention and treatment of arterial thrombosis will be interested in this webinar. In addition vascular biologists, immunologists, platelet researchers, hemostaseologists and clinicians with a focus on thrombotic cardiovascular diseases will be interested in this webinar.
At the conclusion of this activity, I will be able to:
- Understanding hemostasis and thrombosis from a systems perspective
- Optimal and non-optimal responses to injury and disease
- Understanding the interplay between platelet signaling networks, emergent properties and the shaping of hemostatic and thrombotic responses
- Understanding and predicting the impact of antiplatelet agents (alone and in combination)
- To understand the role of innate immune cells in DVT formation
- To know the molecular features mediating the cross-talk between thrombosis and immunity during DVT
Name | Company | Role |
Chris Ward, MD | Bayer | Advisory Board, Speaker |
| Pfizer, BMS | Advisory Board, Speaker |
| Boehringer-Ingelheim | Advisory Board, Speaker |
| Alexion | Advisory Board |
| Medimark | Steering Committee Member, Speaker |
Geoff Barnes | BMS, Pfizer, Blue Cross Blue Shield of Michigan | Primary Investigator & Co-Investigator |
Yukio Ozaki | Sysmex | Advisory Board |
Lawrence Brass | Merck | Consultant |
Janssen | Consultant | |
The Medicines Co. | Research |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.